-- Robert Preidt
TUESDAY, Feb. 15 (HealthDay News) -- Multiple sclerosis is
associated with reduced levels of an important neurotransmitter,
noradrenaline -- a shortage caused by damage to an area of the
brain called the locus coeruleus (LC), researchers have found.
Neurons in this part of the brain are a major source of
noradrenaline, which plays an important role as an
immunosuppressant in the brain, preventing inflammation and stress
"There's a lot of evidence of damage to the LC in Alzheimer's and Parkinson's disease, but this is the first time that it has been demonstrated that there is stress involved to the neurons of the LC of MS patients, and that there is a reduction in brain noradrenaline levels," the study's first author, Paul Polak, a research specialist at the University of Illinois at Chicago, said in a university news release.
He and his colleagues found LC damage and reduced levels of
noradrenaline in mice with MS and detected similar problems in the
brains of people with the disease. The results suggest that LC
damage and an accompanying reduction in noradrenaline levels may be
common to many neurological diseases, they said.
The study was published online Feb. 4 in
"There are a number of FDA-approved drugs that have been shown to raise levels of noradrenaline in the brain, and we believe that this type of therapeutic intervention could benefit patients with MS and other neurodegenerative diseases, and should be investigated," Polak said.
The American Academy of Family Physicians has more about
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.